Verywell Health on MSN1mon
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a ...
Hosted on MSN2mon
FDA approves SPRAVATO as first monotherapy for MDD
The approval of SPRAVATO® as a monotherapy provides a new option for healthcare providers to personalize treatment plans and offer rapid symptom improvement without the need for daily oral ...